CompletedNot Applicable

Survey of Non-Variceal Upper Gastro Intestinal Bleeding in Vietnamese Patients

Vietnam1,044 participantsStarted 2011-10

Plain-language summary

The main aim of the study is to describes the outcomes of patients with Upper Gastrointestinal Bleed (UGIB) in a real-life setting. Additionally analyse assessed predictors of outcome, including the impact of hemostatic endoscopic and pharmacologic therapies.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Adult patients (\>=18yrs) admitted to the hospital, or inpatients admitted for another reason, presenting with overt non-variceal upper GI bleed manifesting as hematemesis/coffee ground vomiting, melena, hematochezia... * Evidence that an upper GI endoscopy was performed Exclusion Criteria: * GI bleeding not from NVUGIB

What they're measuring

Rebleeding (within 7 days from the Non-Variceal Upper Gastro Intestinal Bleeding (NVUGIB) episode)

Timeframe: 7 days

Trial details

NCT IDNCT01292915

SponsorAstraZeneca

Sponsor typeINDUSTRY

Study typeOBSERVATIONAL

Primary completion2013-01

View on ClinicalTrials.gov More Re-bleeding in NVUGIB trials